SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹67 Cr | ₹108 Cr | ₹94 Cr | ₹46 Cr | ₹20 Cr |
What is the latest Total Non-Current Liabilities ratio of SAKAR HEALTHCARE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹67 Cr |
Mar2023 | ₹108 Cr |
Mar2022 | ₹94 Cr |
Mar2021 | ₹46 Cr |
Mar2020 | ₹20 Cr |
How is Total Non-Current Liabilities of SAKAR HEALTHCARE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹67 Cr | -38.00 | |
Mar2023 | ₹108 Cr | 15.99 | |
Mar2022 | ₹94 Cr | 103.03 | |
Mar2021 | ₹46 Cr | 135.46 | |
Mar2020 | ₹20 Cr | - |
Compare Total Non-Current Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹700.3 Cr | -2.6% | 18.3% | -4.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -2.6% |
18.3% |
-4.7% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses